Andreas Kommer - Publications

Bleeding risk after kidney biopsy with platelet inhibition.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: June 13, 2026

Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial.

Journal: The Lancet regional health. Europe

Published: December 19, 2025

Effectiveness of check-up 35 for detecting targeted diseases in Germany.

Journal: BMC primary care

Published: November 07, 2025

Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Single-Center Experience of Biopsy-Proven Cases.

Journal: Journal of clinical medicine

Published: March 19, 2025

Anifrolumab in systemic lupus erythematosus: real-world experience from a single academic tertiary care centre.

Journal: Clinical and experimental rheumatology

Published: March 15, 2025

Chronic kidney disease is associated with incident depression requiring treatment: a retrospective cohort study.

Journal: Clinical kidney journal

Published: October 01, 2024

A20 in Kidney Transplantation and Autoimmunity.

Journal: International journal of molecular sciences

Published: May 10, 2024

Long-term survival of kidney-transplant recipient with donor-transmitted malignant melanoma after provoked rejection.

Journal: Transplant immunology

Published: March 26, 2024

Proton pump inhibitor use and bone fractures in patients with chronic kidney disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: February 16, 2024

Immunoadsorption study Mainz in adults with post-COVID syndrome (IAMPOCO)-a single-blinded sham-controlled crossover trial to evaluate the effect of immunoadsorption on post-COVID syndrome.

Journal: Trials

Published: January 25, 2024